Приказ основних података о документу

dc.creatorKlisić, Aleksandra
dc.creatorCojić, Milena
dc.creatorPatoulias, Dimitrios
dc.creatorNinić, Ana
dc.date.accessioned2023-11-14T14:21:38Z
dc.date.available2023-11-14T14:21:38Z
dc.date.issued2023
dc.identifier.issn2227-9059
dc.identifier.urihttps://farfar.pharmacy.bg.ac.rs/handle/123456789/5228
dc.description.abstractObjective: Previous studies suggested that ethnic differences, sex and obesity could modify the relationship between 25-hydroxyvitamin D [25(OH)D], glycometabolic markers and/or type 2 di- abetes mellitus (T2D). We aimed to examine the potential relationship between [25(OH)D] and T2D in postmenopausal women in Montenegro. In addition, we aimed to explore if a set of biomarkers, rather than [25(OH)D] as a single biomarker, could better explain its potential association with T2D. Patients and Methods: A total of 116 postmenopausal, otherwise healthy women and 48 postmenopausal women with T2D were included. Univariable and multivariable binary logistic regression analy- sis, along with principal component analysis (PCA), were applied to test the associations between examined biomarkers/set of biomarkers with T2D. Results: Women with T2D had lower serum [25(OH)D] levels than healthy controls (p = 0.024). No independent relationship between [25(OH)D] and T2D was found. PCA extracted three significant factors that were associated with T2D, i.e., age-glycometabolic-related factor (i.e., with positive loadings of age, glucose and insulin; OR = 11.321, p < 0.001), obesity-inflammation- related factor (i.e., with positive loadings of hsCRP and WC, and negative loading of [25(OH)D]; (OR = 2.079, p < 0.001)) and lipid-related factor (i.e., with positive loadings of TG and LDL-c, and negative loading of HDL-c; OR = 1.423, p = 0.044). Conclusions: The relationship between [25(OH)D] and T2D is modulated by central obesity (as measured by WC) and inflammation (as measured with hsCRP) in postmenopausal women. Their joint measurement, rather than [25(OH)D] itself, could provide better information for the risk assessment for T2D in postmenopausal women.
dc.publisherMDPI
dc.relationinfo:eu-repo/grantAgreement/MESTD/inst-2020/200161/RS//
dc.rightsopenAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.sourceBiomedicines
dc.subjectinflammation
dc.subjectobesity
dc.subjectvitamin D deficiency
dc.subjectcardiometabolic risk
dc.subjectpostmenopausal
dc.titleMultimarker Approach as More Reliable Method Than Single Vitamin D in Relationship with Type 2 Diabetes Mellitus in Montenegrin Postmenopausal Women
dc.typearticle
dc.rights.licenseBY
dc.citation.volume11
dc.citation.issue10
dc.citation.rankM21~
dc.identifier.doi10.3390/biomedicines11102610
dc.identifier.pmid37892984
dc.identifier.scopus2-s2.0-85175423140
dc.identifier.fulltexthttp://farfar.pharmacy.bg.ac.rs/bitstream/id/14542/Multimarker_Approach_as_pub_2023.pdf
dc.type.versionpublishedVersion


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу